Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
H. L. Voss, S. Godbole, S. Schlumbohm, Y. Schumann, B. Peng, M. Mynarek, S. Rutkowski, M. Dottermusch, M. Dorostkar, A. Korshunov, T. Mair, S. Pfister, P. Neumann, C. Hartmann, J. Weiss, , J. E. Neumann
This study identifies subtype-specific proteome and N-glycan alterations in medulloblastoma that may serve as therapeutic targets.
bioRxiv · Jan 9, 2023 · PreprintCancer Biology